Northern Trust Corp Capricor Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 268,071 shares of CAPR stock, worth $4.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

268,071

Previous 129,613 106.82%

Holding current value

$4.96 Million

Previous $618,000 559.71%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.56 - $15.21 $492,910 - $2.11 Million	138,458 Added 106.82%	268,071 $4.08 Million
Q2 2024 Aug 14, 2024	BUY	$4.63 - $7.09 $43,054 - $65,929	9,299 Added 7.73%	129,613 $618,000
Q1 2024 May 14, 2024	SELL	$3.61 - $6.88 $24,963 - $47,575	-6,915 Reduced 5.44%	120,314 $816,000
Q4 2023 Feb 13, 2024	BUY	$2.71 - $5.08 $60,348 - $113,126	22,269 Added 21.22%	127,229 $622,000
Q3 2023 Nov 13, 2023	SELL	$3.42 - $7.85 $1,870 - $4,293	-547 Reduced 0.52%	104,960 $358,000
Q2 2023 Aug 11, 2023	SELL	$3.76 - $5.05 $1,755 - $2,358	-467 Reduced 0.44%	105,507 $504,000
Q1 2023 May 15, 2023	BUY	$3.78 - $5.03 $4,403 - $5,859	1,165 Added 1.11%	105,974 $447,000
Q4 2022 Feb 13, 2023	SELL	$3.36 - $6.55 $1,666 - $3,248	-496 Reduced 0.47%	104,809 $404,000
Q3 2022 Nov 14, 2022	BUY	$3.61 - $6.08 $14,097 - $23,742	3,905 Added 3.85%	105,305 $631,000
Q2 2022 Aug 12, 2022	SELL	$2.89 - $4.51 $2,950 - $4,604	-1,021 Reduced 1.0%	101,400 $354,000
Q1 2022 May 13, 2022	SELL	$2.83 - $5.68 $4,250 - $8,531	-1,502 Reduced 1.45%	102,421 $351,000
Q4 2021 Feb 08, 2022	SELL	$2.89 - $4.16 $2,164 - $3,115	-749 Reduced 0.72%	103,923 $304,000
Q3 2021 Nov 15, 2021	BUY	$3.8 - $5.23 $1,599 - $2,201	421 Added 0.4%	104,672 $421,000
Q2 2021 Aug 13, 2021	BUY	$3.16 - $5.72 $23,099 - $41,813	7,310 Added 7.54%	104,251 $535,000
Q1 2021 May 12, 2021	SELL	$3.63 - $7.93 $144,738 - $316,192	-39,873 Reduced 29.14%	96,941 $453,000
Q4 2020 Feb 11, 2021	SELL	$3.43 - $5.23 $49,909 - $76,101	-14,551 Reduced 9.61%	136,814 $469,000
Q3 2020 Nov 16, 2020	BUY	$4.08 - $9.81 $11,807 - $28,390	2,894 Added 1.95%	151,365 $795,000
Q2 2020 Aug 14, 2020	BUY	$1.0 - $8.5 $148,471 - $1.26 Million	148,471 New	148,471 $683,000

Others Institutions Holding CAPR

# of Institutions

Shares Held

8.13M

Call Options Held

1.78M

Put Options Held

1.4M

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $450M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Capricor Therapeutics, Inc. Transaction History